fasudil has been researched along with Coronary Restenosis in 2 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 86-year-old woman was admitted with unstable angina pectoris." | 1.32 | [Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report]. ( Fukumoto, Y; Hiroki, J; Hirooka, Y; Shimokawa, H; Takeshita, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, Y | 1 |
| Uwatoku, T | 1 |
| Oi, K | 1 |
| Abe, K | 1 |
| Hattori, T | 1 |
| Morishige, K | 1 |
| Eto, Y | 1 |
| Fukumoto, Y | 2 |
| Nakamura, K | 1 |
| Shibata, Y | 1 |
| Matsuda, T | 1 |
| Takeshita, A | 2 |
| Shimokawa, H | 2 |
| Hiroki, J | 1 |
| Hirooka, Y | 1 |
2 other studies available for fasudil and Coronary Restenosis
| Article | Year |
|---|---|
Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Apoptosis; Blood Proteins; Catheterization; | 2004 |
[Inhibition of Rho-kinase by fasudil preventing anginal attacks associated with spastic angina: a case report].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Aged, 80 and over; Angina, Unstable; Angioplast | 2004 |